- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03634657
EffectivenesS of Additional X-ray PRotection dEviceS in Reducing Scattered Radiation in Radial interventiOn (ESPRESSO)
October 18, 2020 updated by: Tommaso Gori
Wirksamkeit Additiver Strahlenschutzvorrichtungen Zwecks Reduzierung Der Ionisierenden Streustrahlung im Herzkatheterlabor
This study evaluates the radiation exposure of scattered radiation for the interventionalist during coronary angiography using different X-ray protection materials, namely, an X-ray Screen without additional X-ray protection, an X-ray Screen with additional protective strips and an X-ray Screen with additional protective strips AND protective patient cut-outs.
Study Overview
Status
Completed
Study Type
Interventional
Enrollment (Actual)
700
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Rheinland Pfalz
-
Mainz, Rheinland Pfalz, Germany, 55131
- University Medical Center Mainz
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- indication for coronary angiography
Exclusion Criteria:
- none
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Plain X-ray protection shield
|
Coronary angiography with mere X-ray protection shield
|
|
Experimental: Protection shield & X-ray protective strips
|
Coronary angiography with X-ray protection shield & X-ray protective strips
|
|
Experimental: Protection shield & protective strips & patient cut-outs
|
Coronary angiography with X-ray protection shield & X-ray protective strips & X-ray protection patient cut-outs
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Operator dose
Time Frame: Duration of coronary angiography of individuel patient, varies between approximately 5 minutes of radiation (easy access, exclusion coronary heart disease) and app. 3 hours (difficult and complex percutaneous coronary intervention).
|
Dose of radiation measured
|
Duration of coronary angiography of individuel patient, varies between approximately 5 minutes of radiation (easy access, exclusion coronary heart disease) and app. 3 hours (difficult and complex percutaneous coronary intervention).
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Anadol R, Brandt M, Merz N, Knorr M, Ahoopai M, Geyer M, Krompiec D, Wenzel P, Munzel T, Gori T. Effectiveness of additional X-ray protection devices in reducing scattered radiation in radial intervention: the ESPRESSO randomised trial. EuroIntervention. 2020 Oct 23;16(8):663-671. doi: 10.4244/EIJ-D-19-00945.
- Anadol R, Brandt M, Merz N, Knorr M, Ahoopai M, Geyer M, Krompiec D, Wenzel P, Munzel T, Gori T. Effectiveness of additional X-ray protection devices in reducing Scattered radiation in radial interventions: protocol of the ESPRESSO randomised trial. BMJ Open. 2019 Jul 3;9(7):e029509. doi: 10.1136/bmjopen-2019-029509.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 16, 2018
Primary Completion (Actual)
December 31, 2019
Study Completion (Actual)
October 1, 2020
Study Registration Dates
First Submitted
August 8, 2018
First Submitted That Met QC Criteria
August 15, 2018
First Posted (Actual)
August 16, 2018
Study Record Updates
Last Update Posted (Actual)
October 20, 2020
Last Update Submitted That Met QC Criteria
October 18, 2020
Last Verified
October 1, 2020
More Information
Terms related to this study
Other Study ID Numbers
- ESPRESSO
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Exposure of Member of Staff to Medical Diagnostic X-Ray
-
University of ZurichCompletedFocus of the Study: DNA Damage Due to Medical Diagnostic X-raySwitzerland
-
University of ManitobaCompletedStroke, Ischemic | Tomography, X-Ray ComputedCanada
-
Sanford HealthNational Ataxia Foundation; Beyond Batten Disease Foundation; Pitt Hopkins Research... and other collaboratorsRecruitingMitochondrial Diseases | Retinitis Pigmentosa | Myasthenia Gravis | Eosinophilic Gastroenteritis | Moyamoya Disease | Multiple System Atrophy | Leiomyosarcoma | Leukodystrophy | Anal Fistula | Spinocerebellar Ataxia Type 3 | Friedreich Ataxia | Kennedy Disease | Lyme Disease | Hemophagocytic Lymphohistiocytosis | Spinocerebellar... and other conditionsUnited States, Australia
Clinical Trials on Plain X-ray protection shield
-
Chonnam National University HospitalCompleted
-
University Hospital, GenevaCompletedEmergencies | Abdomen, Acute | Diagnostic ImagingSwitzerland
-
Assiut UniversityCompletedPulmonary HypertensionEgypt
-
Assiut UniversityWithdrawn
-
Prim. Prof. Dr. Oliver Findl, MBACompletedEndothelial Cell Loss, Corneal
-
National Cancer Institute (NCI)Active, not recruiting
-
Menoufia UniversityNot yet recruiting
-
Icahn School of Medicine at Mount SinaiNational Heart, Lung, and Blood Institute (NHLBI)CompletedStroke | Aortic Stenosis | Brain Infarction | Cerebrovascular AccidentUnited States, Canada
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Recruiting
-
Fujifilm Medical Systems USA, Inc.TerminatedTibial Fracture | Wrist Injury | Hip InjuryUnited States